LATEST NEWS

Recovery from the virus seems to stimulate protective immunity, but there’s not enough data to determine how long that protection lasts.
The decline seen in some studies is normal, experts say. But scientists must wait to see whether infection confers long-term protection
A small variation has made the novel coronavirus fitter—but not more deadly
International collaboration provides important piece of COVID-19 puzzle
Researchers comb through hundreds of studies to find clues to beating COVID-19
Study finds robust antiviral T cell response in humans with COVID-19 and detects substantial crossreactivity in unexposed individuals; in a piece of good news provides a benchmark for testing of vaccine candidates.
Antibody therapeutics will likely be a critical tool for protecting frontline healthcare workers and those at most risk of SARS-CoV-2 infection
To aid vaccine design, researchers will investigate how a diverse population fights off viral attack
Their analysis provides essential information for vaccine design and the evaluation of diagnostics and vaccine candidates